tradingkey.logo

Evolus rises after posting quarterly profit versus year-ago loss

ReutersMar 4, 2025 10:07 PM

Shares of cosmetic drugmaker Evolus EOLS.O rise 3.7% to $14.88 in extended trade

Co reports adjusted income of $6.7 million in Q4, compared with a year-ago loss of $3.7 million

EOLS sees 2025 rev between $345 million and $355 million, versus Wall Street estimates of $351.3 million — LSEG

Co says annual net revenue can reach at least $700 million by 2028

EOLS rose 4.8% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI